Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Barton Pai

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Journal of the American Pharmacists Association : Japha|December 16, 2014
Keeping kidneys safe: the pharmacist's role in NSAID avoidance in high-risk patientsAmy Barton Pai
Clinical Journal of the American Society of Nephrology : CJASN|January 4, 2018
Why Nomenclature for Pharmacist-Led Interventions Matters: Conquering the State of ConfusionAmy Barton Pai
Clinical Pharmacokinetics|December 3, 2014
Evaluating plasma pharmacokinetics of intravenous iron formulations: judging books by their covers?Amy Barton Pai
Annals of the New York Academy of Sciences|October 14, 2017
Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluationAmy Barton Pai
Advances in Chronic Kidney Disease|March 17, 2016
It is all About "ADME"Amy Barton Pai
Metal Ions in Life Sciences|March 12, 2019
Iron Oxide Nanoparticle Formulations for SupplementationAmy Barton Pai
Health Literacy Research and Practice|July 12, 2019
Health Literacy and Medication Management in Chronic Kidney DiseaseGenevra Galura, Amy Barton Pai
Advances in Chronic Kidney Disease|July 4, 2006
Optimizing antimicrobial therapy for gram-positive bloodstream infections in patients on hemodialysisAmy Barton Pai, Manjunath P Pai
Advances in Chronic Kidney Disease|March 17, 2016
Drug Transporter Function--Implications in CKDMichael H Schwenk, Amy Barton Pai
Advances in Chronic Kidney Disease|August 24, 2010
CKD: Pharmacotherapy in a House of MirrorsCarol L Moore, Amy Barton Pai
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Journal of the American Pharmacists Association : Japha|December 16, 2014
Keeping kidneys safe: the pharmacist's role in NSAID avoidance in high-risk patientsAmy Barton Pai
Clinical Journal of the American Society of Nephrology : CJASN|January 4, 2018
Why Nomenclature for Pharmacist-Led Interventions Matters: Conquering the State of ConfusionAmy Barton Pai
Clinical Pharmacokinetics|December 3, 2014
Evaluating plasma pharmacokinetics of intravenous iron formulations: judging books by their covers?Amy Barton Pai
Annals of the New York Academy of Sciences|October 14, 2017
Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluationAmy Barton Pai
Advances in Chronic Kidney Disease|March 17, 2016
It is all About "ADME"Amy Barton Pai
Metal Ions in Life Sciences|March 12, 2019
Iron Oxide Nanoparticle Formulations for SupplementationAmy Barton Pai
Health Literacy Research and Practice|July 12, 2019
Health Literacy and Medication Management in Chronic Kidney DiseaseGenevra Galura, Amy Barton Pai
Advances in Chronic Kidney Disease|July 4, 2006
Optimizing antimicrobial therapy for gram-positive bloodstream infections in patients on hemodialysisAmy Barton Pai, Manjunath P Pai
Advances in Chronic Kidney Disease|March 17, 2016
Drug Transporter Function--Implications in CKDMichael H Schwenk, Amy Barton Pai
Advances in Chronic Kidney Disease|August 24, 2010
CKD: Pharmacotherapy in a House of MirrorsCarol L Moore, Amy Barton Pai
Pageof 5